FLUI — Fluicell AB Share News
0.000.00%
Last trade - 00:00- SEK53.30m
- SEK52.00m
- SEK6.00m
Brief: Fluicell Q1 EBITDA Loss Widens To SEK 7.7 Mln
Brief: Fluicell Receives Notice Of Allowance From US Patent Office
Brief: Fluicell Launches Eurostars-Funded Development Project On Cardiac Safety Screening
Brief: Fluicell Q4 EBITDA Loss Widens To SEK 8.0 Mln
Brief: Fluicell Decides On Directed Issue Of Units
Brief: Fluicell: Rights Issue Fully Subscribed
Brief: Fluicell Says In-vivo Trials Indicate High Tolerance of Implant Biomaterials
Brief: Fluicell Secures Rights Issue To 81.7%
Brief: Fluicell Initiates In Vivo Studies In Diabetes Treatment
Brief: Fluicell Q3 EBITDA Loss Widens To SEK 5.9 Million
Brief: Fluicell Appoints Carolina Trkulja As CEO
Brief: Fluicell Q2 Operating Loss SEK 7.3 Mln
Brief: Fluicell Says New CFO Joakim Wahlberg Buys Shares For SEK 63,684
Brief: Fluicell Q1 Operating Loss Widens To SEK 5.4 Mln
Brief: Fluicell Recruits Joakim Wahlberg As CFO
Brief: Fluicell Q4 EBITDA Loss Widens To SEK 6.7 Million
Brief: Fluicell Extends Collaboration With Hoffmann-La Roche
Brief: Fluicell CFO Mats Jonasson To Retire
Brief: Fluicell Gets Order From University Of Southern California